The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action

HCV-related liver disease is the main cause of morbidity and mortality of HCV/HIV-1 co-infected patients. Despite the recent advent of anti-HCV direct acting antivirals (DAAs), the treatment of HCV/HIV-1 co-infected patients remains a challenge, as these patients are refractory to most therapies and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallay, Philippe A., Bobardt, Michael D., Chatterji, Udayan, Trepanier, Daniel J., Ure, Daren, Ordonez, Cosme, Foster, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532424/
https://www.ncbi.nlm.nih.gov/pubmed/26263487
http://dx.doi.org/10.1371/journal.pone.0134707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532424/
https://www.ncbi.nlm.nih.gov/pubmed/26263487
http://dx.doi.org/10.1371/journal.pone.0134707

Ejemplares similares